DC CFAR Member, Brad Jones, PhD, has recently been awarded a R21 from the National Institutes of Health entitled"Engineered CTL with Inducible AB Secretion; A Tripartite Attack of HIV Reservoirs". This project will look at engineering the immune system target to eliminate HIV infection found in latent reservoirs.
Click here for more information and to read the full abstract.